☆ 4.2 Article

226th ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands

NEUROMUSCULAR DISORDERS (2018)

Get Full Text
Add to Collection

Journal

NEUROMUSCULAR DISORDERS
Volume 28, Issue 1, Pages 77-86

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2017.10.002

Keywords

Duchenne muscular dystrophy; Biomarker; Dystrophin; MRI; Biobank

Categories

Clinical Neurology Neurosciences

Funding

  1. Association Francaise contre les Myopathies (France)
  2. Deutsche Gesellschaft fur Muskelkranke (Germany)
  3. Muscular Dystrophy Campaign (UK)
  4. Muskelsvindfonden (Denmark)
  5. Prinses Beatrix Spierfonds (The Netherlands)
  6. Schweizerische Stiftung fur die Erforschung der Muskelkrankheiten (Switzerland)
  7. Telethon Foundation (Italy)
  8. Spierziekten Nederland (The Netherlands)
  9. Finnish Neuromuscular Association (Finland)
  10. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061322] Funding Source: NIH RePORTER
  11. NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.